{"entity":{"type":"insider","cik":"0001601896","url":"/insider/0001601896","json_url":"/insider/0001601896.json","name":"Barth Jay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":22,"first":"2016-07-29","last":"2020-10-02","span_basis":"filed_date"},"name_variants":[{"name":"Barth Jay","source":"filing","n_filings":22,"first_seen":"2016-07-29","last_seen":"2020-10-02"}],"transactions":[{"id":2248547,"accession":"0001209191-20-053165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-053165","line_url":"/filing/0001209191-20-053165#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4064.0,"shares_display":"4,064","price_per_share":14.5057,"price_display":"14.51","price_state":"stated","total_value":58951.1648,"total_display":"58,951.16","total_whole":"58,951","shares_owned_after":163204.0,"shares_owned_after_display":"163,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-30","filed_date":"2020-10-02","scope":"insider"},{"id":2083384,"accession":"0001209191-20-049131","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049131","line_url":"/filing/0001209191-20-049131#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28750.0,"shares_display":"28,750","price_per_share":14.739,"price_display":"14.74","price_state":"stated","total_value":423746.25,"total_display":"423,746.25","total_whole":"423,746","shares_owned_after":163204.0,"shares_owned_after_display":"163,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-31","filed_date":"2020-09-02","scope":"insider"},{"id":2881661,"accession":"0001209191-20-044005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-044005","line_url":"/filing/0001209191-20-044005#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":15.0459,"price_display":"15.05","price_state":"stated","total_value":451377.0,"total_display":"451,377.00","total_whole":"451,377","shares_owned_after":163204.0,"shares_owned_after_display":"163,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-27","filed_date":"2020-07-29","scope":"insider"},{"id":2511228,"accession":"0001209191-20-042311","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-042311","line_url":"/filing/0001209191-20-042311#line-7","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28843.0,"shares_display":"28,843","price_per_share":15.6514,"price_display":"15.65","price_state":"stated","total_value":451433.3302,"total_display":"451,433.33","total_whole":"451,433","shares_owned_after":163204.0,"shares_owned_after_display":"163,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-13","scope":"insider"},{"id":2511218,"accession":"0001209191-20-042311","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-042311","line_url":"/filing/0001209191-20-042311#line-5","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44447.0,"shares_display":"44,447","price_per_share":15.9177,"price_display":"15.92","price_state":"stated","total_value":707494.0119,"total_display":"707,494.01","total_whole":"707,494","shares_owned_after":163204.0,"shares_owned_after_display":"163,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-09","filed_date":"2020-07-13","scope":"insider"},{"id":2900477,"accession":"0001209191-20-042033","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-20-042033","line_url":"/filing/0001209191-20-042033#line-10","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64110.0,"shares_display":"64,110","price_per_share":15.9191,"price_display":"15.92","price_state":"stated","total_value":1020573.501,"total_display":"1,020,573.50","total_whole":"1,020,574","shares_owned_after":163204.0,"shares_owned_after_display":"163,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-08","filed_date":"2020-07-09","scope":"insider"},{"id":2900452,"accession":"0001209191-20-042033","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-042033","line_url":"/filing/0001209191-20-042033#line-5","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178988.0,"shares_display":"178,988","price_per_share":15.9002,"price_display":"15.90","price_state":"stated","total_value":2845944.9976,"total_display":"2,845,945.00","total_whole":"2,845,945","shares_owned_after":163204.0,"shares_owned_after_display":"163,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-09","scope":"insider"},{"id":2287514,"accession":"0001209191-20-039926","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-039926","line_url":"/filing/0001209191-20-039926#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":15.5065,"price_display":"15.51","price_state":"stated","total_value":465195.0,"total_display":"465,195.00","total_whole":"465,195","shares_owned_after":163204.0,"shares_owned_after_display":"163,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-07-01","scope":"insider"},{"id":2881103,"accession":"0001209191-20-037471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-037471","line_url":"/filing/0001209191-20-037471#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1904.0,"shares_display":"1,904","price_per_share":13.4661,"price_display":"13.47","price_state":"stated","total_value":25639.4544,"total_display":"25,639.45","total_whole":"25,639","shares_owned_after":163204.0,"shares_owned_after_display":"163,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-17","filed_date":"2020-06-17","scope":"insider"},{"id":3233570,"accession":"0001209191-20-004125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-004125","line_url":"/filing/0001209191-20-004125#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20720.0,"shares_display":"20,720","price_per_share":10.3455,"price_display":"10.35","price_state":"stated","total_value":214358.76,"total_display":"214,358.76","total_whole":"214,359","shares_owned_after":156473.0,"shares_owned_after_display":"156,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-15","filed_date":"2020-01-17","scope":"insider"},{"id":2282974,"accession":"0001209191-20-002629","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-002629","line_url":"/filing/0001209191-20-002629#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9938.0,"shares_display":"9,938","price_per_share":9.356,"price_display":"9.36","price_state":"stated","total_value":92979.928,"total_display":"92,979.93","total_whole":"92,980","shares_owned_after":156473.0,"shares_owned_after_display":"156,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-08","scope":"insider"},{"id":2282967,"accession":"0001209191-20-002629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002629","line_url":"/filing/0001209191-20-002629#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6836.0,"shares_display":"6,836","price_per_share":9.2766,"price_display":"9.28","price_state":"stated","total_value":63414.8376,"total_display":"63,414.84","total_whole":"63,415","shares_owned_after":166411.0,"shares_owned_after_display":"166,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-08","scope":"insider"},{"id":2266855,"accession":"0001209191-20-001233","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-001233","line_url":"/filing/0001209191-20-001233#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9753.0,"shares_display":"9,753","price_per_share":9.5533,"price_display":"9.55","price_state":"stated","total_value":93173.3349,"total_display":"93,173.33","total_whole":"93,173","shares_owned_after":189522.0,"shares_owned_after_display":"189,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-03","scope":"insider"},{"id":7788848,"accession":"0001209191-19-023978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-023978","line_url":"/filing/0001209191-19-023978#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":14.2039,"price_display":"14.20","price_state":"stated","total_value":710195.0,"total_display":"710,195.00","total_whole":"710,195","shares_owned_after":129767.0,"shares_owned_after_display":"129,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-05","filed_date":"2019-04-08","scope":"insider"},{"id":8615602,"accession":"0001209191-19-014162","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-014162","line_url":"/filing/0001209191-19-014162","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS, INC.","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":12.5162,"price_display":"12.52","price_state":"stated","total_value":876134.0,"total_display":"876,134.00","total_whole":"876,134","shares_owned_after":129767.0,"shares_owned_after_display":"129,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider","n_lines":2},{"id":6291369,"accession":"0001209191-18-030332","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-030332","line_url":"/filing/0001209191-18-030332#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.0445,"price_display":"14.04","price_state":"stated","total_value":70222.5,"total_display":"70,222.50","total_whole":"70,223","shares_owned_after":85409.0,"shares_owned_after_display":"85,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-14","filed_date":"2018-05-15","scope":"insider"},{"id":6659262,"accession":"0001209191-18-025031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-025031","line_url":"/filing/0001209191-18-025031#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.7204,"price_display":"14.72","price_state":"stated","total_value":73602.0,"total_display":"73,602.00","total_whole":"73,602","shares_owned_after":85409.0,"shares_owned_after_display":"85,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-12","filed_date":"2018-04-16","scope":"insider"},{"id":6494495,"accession":"0001209191-18-019413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-019413","line_url":"/filing/0001209191-18-019413#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.0505,"price_display":"15.05","price_state":"stated","total_value":75252.5,"total_display":"75,252.50","total_whole":"75,253","shares_owned_after":85409.0,"shares_owned_after_display":"85,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-13","scope":"insider"},{"id":6392971,"accession":"0001209191-18-005366","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-005366","line_url":"/filing/0001209191-18-005366#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":16.8,"price_display":"16.80","price_state":"stated","total_value":336000.0,"total_display":"336,000.00","total_whole":"336,000","shares_owned_after":85409.0,"shares_owned_after_display":"85,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-25","scope":"insider"},{"id":6757184,"accession":"0001209191-18-002059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-002059","line_url":"/filing/0001209191-18-002059#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.7118,"price_display":"14.71","price_state":"stated","total_value":73559.0,"total_display":"73,559.00","total_whole":"73,559","shares_owned_after":64184.0,"shares_owned_after_display":"64,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":5211145,"accession":"0001209191-17-064095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-064095","line_url":"/filing/0001209191-17-064095#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.5874,"price_display":"13.59","price_state":"stated","total_value":67937.0,"total_display":"67,937.00","total_whole":"67,937","shares_owned_after":64184.0,"shares_owned_after_display":"64,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4452396,"accession":"0001209191-17-057056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-057056","line_url":"/filing/0001209191-17-057056#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.2536,"price_display":"14.25","price_state":"stated","total_value":71268.0,"total_display":"71,268.00","total_whole":"71,268","shares_owned_after":64184.0,"shares_owned_after_display":"64,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-12","filed_date":"2017-10-16","scope":"insider"},{"id":4541384,"accession":"0001209191-17-040794","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-040794","line_url":"/filing/0001209191-17-040794#line-3","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":64184.0,"shares_owned_after_display":"64,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-19","scope":"insider"},{"id":2926268,"accession":"0001209191-16-135865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-135865","line_url":"/filing/0001209191-16-135865#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10458.0,"shares_display":"10,458","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":73206.0,"total_display":"73,206.00","total_whole":"73,206","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-04","filed_date":"2016-08-08","scope":"insider"},{"id":2551117,"accession":"0001209191-16-134472","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-134472","line_url":"/filing/0001209191-16-134472#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001601896","owner_name":"Barth Jay","owner_display_name":"Barth Jay","owner_url":"/insider/0001601896","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20916.0,"shares_display":"20,916","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":146412.0,"total_display":"146,412.00","total_whole":"146,412","shares_owned_after":25458.0,"shares_owned_after_display":"25,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-27","filed_date":"2016-07-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS, INC.","url":"/issuer/0001178879","role":"Officer (Chief Medical Officer)","n_filings":22,"first_seen":"2016-07-29","last_seen":"2020-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001601896","retrieved_at":"2026-08-22T08:03:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}